Ignite Creation Date:
2025-12-24 @ 12:55 PM
Ignite Modification Date:
2025-12-29 @ 4:10 PM
Study NCT ID:
NCT00895661
Status:
COMPLETED
Last Update Posted:
2017-06-09
First Post:
2009-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
High Dose Rituximab for Initial Treatment of Indolent B-Cell Lymphomas
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
ACTUAL
Primary Completion Date:
2010-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-08
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-06
First Submit QC Date:
None
Study First Post Date:
2009-05-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-03-29
Results First Submit QC Date:
None
Results First Post Date:
2017-05-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-09
Last Update Post Date:
2017-06-09
Last Update Post Date Type:
ACTUAL